Products

Formassign

FormAssign은 온라인 신청서 제작, 담당자 배정·제출 관리 서비스입니다.

formassign.com Business Operations / Forms & Surveys

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$2.92/mo
Lower than 98% of peersNiche median $15/mo
Creators
sillysink
No social account linked
Launched
11mo ago
2026-01-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions

  • New product launchLaunch

    Jan 3 · 11mo agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-01-03

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

무료 요금제
Unknown
동시 운영 폼 3개 · 일 30회 제출
Standard
월 4,000원
Pro
월 10,000원
Business
월 15,000원

Trial: None · Observed 2026-11-06 · Source page

Entry price $2.92/mo, Lower than 98% of peers; “Forms & Surveys” median is $15/mo.View pricing benchmark

Pages & changes

Tracked since 2026-08-11

Key pages

Weekly snapshots
Home
formassign.com/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Formassign cost?
무료 요금제: Unknown; Standard: 월 4,000원; Pro: 월 10,000원; Business: 월 15,000원. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Formassign get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Formassign and what platforms does it support?
Formassign is catalogued under Forms & Surveys: FormAssign은 온라인 신청서 제작, 담당자 배정·제출 관리 서비스입니다.. Supported platforms: Web.

Related products in this category

Business Operations / Forms & Surveys

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.